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1. INTRODUCTION 
The constant need for materials with new or improved functionalities has provoked 
a wide use of nanotechnology in consumer and industrial product development. 
Engineered nanomaterials (less than 100 nm in at least one dimension) have unique 
properties compared to the respective bulk material making them desirable in a 
wide range of applications.  
Many consumer products aim to prevent the spread of microbes. Silver 
nanoparticles (Ag NPs) are one of the most frequently used nanomaterials (NMs) 
in consumer products as Ag is known for its antimicrobial properties. Anti-
microbial products are meant to kill or inhibit the growth of predominantly bacteria 
without causing harm to so-called non-target organisms. Therefore, the potential 
toxic effects of antimicrobial materials, including NPs towards humans as one of 
the non-target organisms need to be understood to enable their safe implementa-
tion. NMs are not considered dangerous per se, but dangers and uncertainties in 
many aspects regarding their safe use still exist. 
Particle physico-chemical properties, such as size, shape and surface pro-
perties, as well as the surrounding media, can significantly affect NP influence 
through altering particle-cell interactions. One of the main toxicity pathways of 
some NPs, e.g., Ag NPs is their dissolution and release of metal ions. Therefore, 
dissolution of NPs is a characteristic that needs a special attention in toxicity 
assessment. Lack of suitable methods for visualization and quantification of  
NP-cell interactions has not enabled to clarify whether the toxic effects of Ag 
NPs are caused by cell surface-bound NPs resulting in local dissolution and 
release of Ag+ ions or by internalized Ag NPs. Therefore, methods need to be 
combined to relate cell-particle interactions with cytotoxicity. Understanding of 
nanoparticle toxic properties allows proceeding with product development 
without affecting the environment and human health. 
A promising perspective for NP use is their application in antimicrobial 
coatings with the ability to inhibit bacterial growth and even degrade organic 
residues from the surface. The most often used NPs in such applications are 
metallic and metal oxide NPs. NPs of Ag and ZnO exhibit their effect through 
enhanced release of metal ions resulting from the large surface area of the NPs. 
NPs of metal oxides such as TiO2 and ZnO are photocatalytically active, i.e., hinder 
microbe growth and degrade various organic contaminants under specific lighting 
conditions. Therefore, a formation of nanoparticulate photocatalytic material in 
combination with antimicrobial metallic NPs would result in a combined effect 
of antimicrobial ions and photocatalysis. 
The purpose of the current study was to gain knowledge on the toxicity of 
nanosized Ag particles with different physico-chemical properties. The improved 
knowledge was expected to contribute to the development of novel and sustain-
able antimicrobial coatings. As a result of the study we propose an antimicrobial 
coating that is based on a combination of photocatalytic and antimicrobial metallic 
NPs that enable efficient inhibition of bacterial growth as well as degradation of 
organic material on surfaces. We also demonstrate the reusability of our coatings 
which to our best knowledge hasn’t been done before for this type of coatings.  
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2. AIMS OF THE STUDY 
The present thesis aims to develop nanoparticle-based antimicrobial coatings that 
efficiently inhibit the growth of pathogenic bacteria but are safe for human use. 
The specific aims were: 
 
 to clarify the role of physico-chemical properties (shape, size, surface 
charge and dissolution) of the most widely used antimicrobial nano-
particles’ effects towards model pathogenic bacteria and relevant mam-
malian cell lines; 
 to study the mechanisms behind antimicrobial action of photocatalyti-
cally active surfaces; 
 to design and propose safe nanoparticle combinations for antimicrobial 
surface coatings with enhanced photocatalytic and antimicrobial effect. 
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3. LITERATURE REVIEW 
3.1. Advantages and challenges related to nanomaterials 
The definition for “nanomaterial” varies slightly in different European Union 
legislations and is under constant revision1, 2 but overall, nanomaterials (NMs) 
are classified on the basis of size and are considered to be materials with at least 
one dimension in the range of 1–100 nm or particles in agglomerates or 
aggregates whenever the constituent particles are in the mentioned size range3. 
The current work focuses on particles in nanoscale size range i.e. nanoparticles 
(NPs). The interest towards nano-scale materials and processes has emerged due 
to unique physico-chemical properties of NPs that arise mostly due to increased 
specific surface area compared to the bulk substance. The significantly increased 
specific surface area of NPs in turn results in increased surface reactivity due to 
high ratio of surface atoms. Although natural (incl. incidental) nanosized matter 
has always existed in the environment (e.g. released during combustion processes 
like volcano eruptions) and surrounded humans, the emergence of nano-
technology and engineered NPs has put the environment and humans in a novel 
situation4. Current synthesis methods enable the production of particles with a 
wide range of physico-chemical properties e.g. size, shape, crystallinity, 
composition, surface properties. Spherical NPs are most commonly produced and 
used however, differently shaped particles (nanowires, nanocubes, nanoplates, 
nanorods etc) have been shown to have great potential in specific applications. For 
example, Ag or ZnO nanowires could potentially be used in electro-optical 
applications like solar cells5–7 and Ag nanoplates show potential as a contrast 
agent in tumour imaging8. 
NPs find use in various applications due to their enhanced optical, mechanical, 
electrical, catalytic, biologic etc activity4. The properties required for techno-
logical applications may lead to increased bioavailability and toxicity of NPs 
compared to bulk and microsized compounds. Although NMs are not considered 
dangerous per se, there exist risks regarding their safe use. Consumer products 
mostly make use of the novel properties of metal-based NPs among which Ag 
NPs with well-known antimicrobial properties are currently the most used NPs9. 
The data on toxicological impact of NPs are just emerging and still lag behind the 
design of new NMs10, 11.  
Probably the biggest challenge regards antimicrobial NPs that are meant to be 
toxic towards microbes per se. These particles however should not affect the non-
target cells and organisms. Among the three well-known antimicrobial and 
biocidal NPs (Ag, ZnO, CuO), Ag NPs have been shown to be the most toxic 
towards environmentally relevant (non-target) organisms12, such as environment-
inhabiting bacteria and plants, at environmentally relevant concentrations13. The 
estimated annual production of Ag NPs in Europe is ~10 tons14 and Ag NPs have 
demonstrated to exhibit toxic effects. Therefore, the need to understand the 
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magnitude of potential toxicity of nanoscale Ag towards non-target environ-
mental organisms and the human is of great importance. In the following chapters 
(i) the toxicity pathways of metal-based NPs and (ii) the effect of NP physico-
chemical properties on their biological activity and NP-cell interactions will be 
introduced. Ag NPs as the most widely used metal-based NPs will be in the focus. 
 
 
3.2. Toxicity mechanisms of metal-based nanoparticles 
Generally, three major phenomena drive the toxicity of metal-based NPs: 
(i) release of ions during dissolution of NPs, (ii) organism dependent cellular 
uptake of NPs and (iii) induction of oxidative stress and the consequent cellular 
damages15. The toxic effect of metal-based CuO, ZnO and Ag NPs has been 
shown to be mediated by dissolved ions12. Also, reactive oxygen species (ROS)-
induced oxidative stress and the resulting physiological effects of Ag, ZnO and 
CuO NPs have been demonstrated at almost all the levels of biological organi-
zation, from bacteria to fish as well as in mammalian cell lines in vitro15. 
Induction of ROS in addition to ion release is one of the best acknowledged 
mechanism of toxicity of Ag NPs16. However, Ag NPs’ toxicity mechanisms in 
the case of bacteria and mammalian cells are somewhat different. 
In the case of bacteria, toxicity of Ag NPs (which is driving also the anti-
bacterial effects of these NPs) is shown to be driven by (i) adherence to the 
surface of the cell membrane and the following disturbance of membrane perme-
ability and respiration17, (ii) penetration of the cell membrane and induction of 
the subsequent physiological effects18 and (iii) release of silver ions19–21 
(Figure 1). 
Adherence of Ag NPs to bacterial membrane has been proven using electron 
microscopy18 and atomic force microscopy22. Morones et al. 2005 suggest that 
Ag NPs increase bacterial membrane permeability making it possible for particles 
to penetrate the cell19. Kumar et al. claim cellular uptake of TiO2 and ZnO NPs 
by Salmonella typhimurium using TEM and flow cytometry analysis23. However, 
for bacteria, internalization of NPs due to rigid cell wall is rather an exception 
and mostly reported as a side-effect. 
Increased adherence enhances Ag bioavailability which leads to increased 
interference with the normal function of the bacterial electron transport chain and 
ROS formation at the cell membrane22. Bactericidal action of Ag NPs can be 
attributed to disruptions in ATP generation due to altered respiratory electron 
transport, increased membrane permeability, inhibition of respiratory chain 
enzymes and generation of ROS24. Increased ROS levels can be the result of 
disruptions in ROS regulatory pathways24 as Ag+ ions released from Ag NPs are 
proposed to strongly interact with thiol groups of vital enzymes and inactivate 
them19. Also, loss of DNA replication ability and structural changes in the cell 
membrane have been reported to occur after Ag+ ion treatment25. The importance 
of Ag+ ions in Ag NPs toxicity has been proven by the diminished toxicity in 
anaerobic conditions due to the lack of oxidative dissolution and subsequent ion 
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release20. Lok et al. have as well shown that chemisorbed Ag+ is the cause for Ag 
NP antimicrobial activity as reduced Ag NPs (particles without chemisorbed 
ions) did not cause antibacterial effect26. Direct contact between Ag NPs and 
bacterial cells has proven to be a prerequisite for enhanced Ag NP antibacterial 
effect due to additional dissolution taking place at particle-cell interface21. 
Antimicrobial effects of NPs can be bacteria-specific due to differences in cell 
membrane structure. For example, Gram-positive bacteria Staphylococcus aureus 
is shown to be less susceptible to Ag NPs than Gram-negative Escherichia coli27. 
Less pronounced changes in cell morphology of S. aureus compared to E. coli 
after Ag+ treatment suggests a defense mechanism of S. aureus25. However, 
different susceptibility to Ag NPs has also been observed for bacteria with similar 
membrane structure, e.g., Gram-negative Pseudomonas aeruginosa and Vibrio 
cholerae have been shown to be more resistant to Ag NP toxicity than Gram-
negative E. coli19. Recently, it has been concluded that there is a need to study 
the bacterial transcriptomic profile in relation to the proteomic profile to 
comprehensively elucidate the molecular mechanisms behind Ag NP bactericidal 
action24. 
 
 
Figure 1. The effects of Ag nanoparticles (NPs) on the bacterial cell. Ag NPs and Ag+ 
ions released from the particles can damage bacterial cell membrane and disturb 
membrane permeability and respiration causing cytoplasmic leakage. Internalized Ag 
NPs and Ag+ ions induce increased ROS generation and cause subsequent physiological 
effects (e.g. DNA damage, protein denaturation). Modified from (Pareek et al. 2018)24. 
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In the case of mammalian cells, differently from the bacteria, the uptake of NPs 
is a very common scenario. Caveolae- and clathrin-mediated endocytosis have 
been shown to be the main contributors to NP uptake28, 29. By using uptake 
inhibitors it has been suggested that lipid-raft mediated endocytosis, energy-
dependent uptake pathways and energy-independent diffusion are all involved in 
the uptake of Ag NPs30. The preferred uptake pathways have been shown to be 
NP specific and depend on NP parameters such as composition, size, shape and 
surface chemistry as well as on purity of the particles, incubation conditions and 
cell types28. Particle sizes suitable for uptake range from 10 to 500 nm, but 40–
50 nm diameter seems to be the optimal NP size for cellular binding and 
internalization31. The internalized NPs generally translocate to endosomal or 
lysosomal vesicles for further elimination. Internalized NPs can cause 
cytotoxicity i.e. toxicity to mammalian cells through the production of ROS and 
direct mitochondrial damage31. The significance of Ag+ ions in toxicity towards 
mammalian cells is well-studied. Ag NPs may facilitate the entrance of Ag+ ions 
into mammalian cells by so called “Trojan horse” mechanism by which the 
internalized NPs dissolve and by that, increase the bioavailability of silver32. The 
released Ag+ ions cause cytotoxicity while intracellular localization of NPs is not 
that important32. A study investigating the fate of intracellular Ag NPs suggested 
that internalized Ag NPs dissolve quickly and the released ions bind to SH-groups 
in amino acids or proteins and subsequently affect protein functions and 
antioxidant defense system of the cells30 (e.g. the depletion of glutathione (GSH) 
and reduction of the superoxide dismutase (SOD) enzyme activity). As SODs and 
GSH-dependent enzymes are the major enzymatic antioxidants in cells33, 
depletion of GSH level increases oxidative stress. Increased amount of reactive 
oxygen radicals stimulated by Ag NPs may be an important factor in their 
genotoxic effects30, 34. Although ROS generation is one of the most frequently 
reported NP-associated toxicity mechanisms35, Chairuangkitti et al. have reported 
both ROS-dependent (cytotoxicity) and ROS-independent (cell cycle arrest) 
pathways for Ag NP toxicity in A549 cells (human alveolar epithelial cells)36. A 
question concerning metal ion releasing particles is whether the oxidative stress 
experienced by cells is directly induced by extracellular or internalized NPs, 
caused by the released ions or a combination of nano-specific NP-cell interactions 
resulting in increased levels of bioavailable metal ions. 
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3.3. The effect of nanoparticle physico-chemical  
properties on their biological activity and  
nanoparticle-cell interactions 
The interactions between NPs and organisms can be complex and vary depending 
on the characteristics of the particles, types of cells (prokaryotic and eukaryotic) 
and organisms involved and the properties of the exposure media. Metal-based 
NP-cell interactions can be roughly classified as (i) adherence to the cell 
membrane, (ii) penetration of the damaged cell membrane, (iii) internalization by 
regulated uptake pathways, (iv) extracellular or intracellular release of metal ions 
and the subsequent interaction with cells. 
Physico-chemical properties (size, shape, composition and surface properties 
such as surface coating) of metal-based NPs may significantly affect particle 
toxicity through either altered NP-cell interactions or variations in particle 
dissolution, both of which may increase the bioavailable portion of the metal 
component of NPs12, 15, 24, 37. The extent of NP dissolution is suggested to additio-
nally depend on the properties of the surrounding media. For instance stable 
colloidal Ag NPs can lead to increased cell-NP association and/or dissolution and 
consequently to higher toxicity37. The importance of proper particle charac-
terization in relevant test conditions has been emphasized12 and the lack of coherent 
test conditions and proper characterization may be the reason for controversial 
data gained by different research groups. The following chapters will describe 
physico-chemical characterization of NPs and size, shape and surface properties-
based biological effects of metal-based NPs on bacterial and mammalian cells 
with the emphasis on Ag NPs. 
 
 
3.3.1. Physico-chemical characterization of nanoparticles 
A prerequisite for a well-devised and executed study is the appropriate charac-
terization of NPs to make the claims and conclusions of the study38. Important 
aspects of NP characterization can be classified into three main groups: physico-
chemical properties, biological and environmental fate, and (re)activity39. Physico-
chemical properties of NPs can be divided into (i) intrinsic material properties 
which include chemical composition, size, size distribution, shape, crystal 
structure, crystallinity and surface characteristics and (ii) extrinsic (altered by the 
environment) properties which include hydrodynamic diameter, the extent of 
aggregation or agglomeration, composition of bio-corona, zeta-potential and 
dissolution40. In the case of metal and metal oxide NPs dissolution properties are 
particularly important to investigate as the release of ionic components must be 
taken into consideration41. Analysis of NPs’ extrinsic properties in relevant bio-
logical environments poses a challenge due to low realistic NP concentrations and 
the presence of natural nanoparticulate matter which may complicate analysis42. 
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However, knowledge of intrinsic properties or so-called particle synthetic identity 
may help to predict their biological fate and physiological activity40. 
NPs’ properties can be studied using a variety of methods and generally a 
combination of techniques is used to enable sufficient characterization. Methods 
for characterization of nanosized matter include electron microscopy (SEM, 
TEM) and light scattering methods (e.g. DLS) for size, size distribution and 
aggregation state measurement, spectroscopy methods (e.g. EDX, XPS, UV-Vis) 
for chemical composition analysis, atomic spectrometry techniques (e.g. AAS, 
ICP-MS) for elemental analysis and zeta-potential measurement for surface 
charge and colloidal stability analysis39, 42. NPs’ inherent reactivity is analysed by 
measuring their redox potential, radical formation potential and photocatalytic 
activity39. Sample preparation for characterization may alter NP characteristics 
(e.g. effects from drying in the case of electron microscopy samples or effects 
from dispersion protocols which affect the degree of particle agglomeration) and 
that must be taken into consideration when interpreting the results.  
It is advisable to characterize several common NP parameters to describe what 
the particle is made of (chemical composition), what it looks like (size, size 
distribution, shape) and which factors influence their biological effects (e.g. 
surface charge, solubility). At the same time, it is important to keep in mind that 
the choice of the NP characteristics to be measured more accurately should be fit-
for-purpose i.e. tailored to the end point being studied40. 
 
 
3.3.2. Effects on bacterial cells 
As explained in the previous chapter, interaction of dissolved Ag+ ions from Ag 
NPs is one of the main cellular interaction mechanisms for Ag NPs, but physico-
chemical properties of Ag NPs have been shown to highly influence the type and 
degree of interactions with bacterial cells24. In general, smaller particles tend to 
induce higher antibacterial activity independent of the NP constituent material31. 
Several studies have concluded that smaller Ag NPs cause higher antimicrobial 
activity due to increased release of Ag+ ions43–45. Increased dissolution, accom-
panying decreasing particle size often explains the tendencies observed in anti-
bacterial effect46. However, for non-soluble NPs lower antimicrobial effect for 
smaller NPs47 or no evident size-dependent toxicity48 has been published. 
It has also been observed that the shape of Ag NPs can impact their anti-
microbial activity. Compared to spherical and rod-shaped Ag NPs triangular 
nanoplates showed higher antibacterial activity49. Sadeghi et al. reported that Ag 
nanoplates had higher antibacterial effect than Ag nanorods with Ag nanospheres 
being the least effective50. Higher area of active crystal facets with high biological 
reactivity has been claimed to be the cause for increased antimicrobial activity of 
Ag triangular nanoplates compared to spherical or rod-shaped particles49, 50. 
Namely, the dissolution of Ag from [111] crystal facets (predominant in rod- and 
plate shaped NPs) is easier which consequently leads to increased Ag+ release51. 
Controversially in another study, Ag nanoplates were reported to be less 
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antibacterial than spherical and rod-shaped particles52. Shape-dependent toxicity 
has been shown for other environmentally relevant organisms. Ag nanoplates 
induced higher toxicity towards zebrafish embryos compared to spherical 
particles53. Shape-dependent antibacterial activity has also been shown for non-
soluble materials in which case the adverse effects are not due to chemical (ion-
based) but physical reasons. For example rod-shaped carbon structures were 
reported to puncture bacterial cell membranes54. 
Particle surface can be intentionally functionalized using different ligands. 
Selection of capping material is relevant as it can significantly affect the dis-
solution kinetics and release of active silver ions from the surface of Ag NPs24. 
At the same time, in a media containing proteins and other organics, particles 
tend to spontaneously accumulate an organic surface coating which affects 
solubility and toxicity of metal NPs12. Particle surface properties can also affect 
cell-NP interactions. Compared to negatively charged particles, positively charged 
Ag particles have higher adherence affinity for bacterial surface, causing enhanced 
antibacterial effect22, 51 due to higher Ag bioavailability22 and destruction of 
membrane causing leakage of cellular material55. 
 
 
3.3.3. Effects on mammalian cells 
As majority of Ag containing consumer products come into contact with humans, 
toxicity for the human as one of the non-target organisms is studied to evaluate 
material safety. Ag NP toxicity towards human cells is known from a number of 
studies12. The choice of mammalian cell line for a study depends on the relevant 
NP exposure scenario. NPs may invade the human body via inhalation, ingestion 
or through skin and therefore toxic effects towards lung cells, blood cells, 
epidermis cells etc are studied. The potential use of Ag NPs in drug delivery and 
targeting56 has also raised the need to understand Ag NP-cell interactions on 
tissue cells29. 
Cytotoxicity of NPs has been shown to be particle size dependent. Smaller Ag 
and Au particles have been shown to induce more significant effects than bigger 
ones due to increased particle internalization57, oxidative stress46, necrosis and 
apoptosis58 and depletion of glutathione (GSH) level57. The size of the NP alone 
may not be responsible for cytotoxicity, but the total particle number per unit 
volume may be important. Smaller particles occupy less volume and therefore 
larger number of particles can occupy a unit area, resulting in increased oxidative 
stress, ROS generation or mitochondrial perturbation59. Shang et al. have 
concluded that smaller NPs have a higher probability to be internalized by living 
cells and more likely cause toxic cellular responses60. 
Cellular uptake of NPs has been shown to be shape-dependent: shorter Au 
nanorods internalize more easily as particles with higher aspect ratio take longer 
time to internalize through endocytosis28, 61. Shape-dependence can be cell line 
specific. Graf et al. showed higher nanoprism uptake compared to spherical NPs 
by cells with flexible cell membrane compared to stiff membrane62. Cells with 
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rather stiff membrane showed no NP shape-dependent affinity62. Shape-related 
studies with fish gill epithelial cells and zebrafish embryos63 and cell cultures64 
also indicate potential shape-specific effect of rod/wire-shaped particles. 
Particle surface properties greatly influence cell-NP interactions. Surface 
coating may affect particle surface charge and subsequently alter particles’ 
behaviour. Positively charged Au65, SiO266, TiO267 and Ag22 particles have been 
shown to associate with cells more readily compared to negatively charged 
particles. Surface charge also affects the cellular uptake mechanism – positively 
charged particles are taken up rapidly by clathrin-mediated endocytosis, but 
negatively charged particles show inferior rate of endocytosis28, 68. Ag NPs with 
different coating material can induce unlike toxic effects due to different ability 
of the coating material to complex released Ag+ ions46. The fate of particles after 
uptake must be considered as the particles may dissolve (e.g. Ag+ ions induce 
ROS directly or influence the work of ROS scavengers). The study by Jiang et al. 
claimed that 80% of Ag NPs taken up by the cells were dissolved after 24 h 
incubation and after cellular uptake silver changes overtime from Ag0 to Ag-O- 
to Ag-S- form30. 
Among the listed parameters surface chemical composition/modification is 
claimed to be one of the most efficient means to control and modulate interactions 
between NPs and mammalian cells. NP’s surface properties greatly depend on 
surrounding media: biomolecules (proteins, natural organics etc) can adsorb onto 
the surface and thereby functionalize the particle. A subsequent protein corona69 
formed around NPs alter the behaviour of the particle70. At the same time, the 
possibility to functionalize NPs e.g. using specific proteins enable the development 
of highly efficient and specific drug-delivery options. Cell-specific uptake 
mechanisms and pathways are essential properties when designing cancer 
treatment drugs which selectively kill cancer cells without affecting normal cells71.  
Due to the lack of suitable methods enabling visualization and quantification 
of cell-particle interactions, it is not clear whether the toxic effects of Ag NPs are 
caused by cell surface-bound particles resulting in local Ag dissolution or by 
internalized Ag NPs32, 72. Many microscopy techniques exist for qualitative 
evaluation of cell-NP interactions73 but they often don’t achieve nanoscale 
resolution/sensitivity (e.g. light microscopy or dark-field microscopy74), need 
specially labelled NPs (fluorescence microscopy75) or excessive sample pre-
paration that may introduce possible artefacts (electron microscopy73) and the 
results can’t be directly linked to quantitative toxicological results. Enhanced 
dark-field microscopy on the other hand is specifically designed to allow 
visualization of particles as small as 10 nm76. Flow cytometry is another 
promising method for studying cell-NP interactions. Cell-association of TiO2, 
Ag, SiO2 and Fe3O4 NPs has been characterized using flow cytometry and the 
detected NPs have been assumed to be intracellularized66, 67, 77–79. Only a few 
studies have attempted to quantify cell-associated NPs. For example Böhme et al. 
used flow cytometry together with ICP-MS to quantify the uptake of Al2O3 NPs 
by skin keratinocytes and lung epithelial cells80. Selective chemical etching that 
removes cell surface bound NPs has been utilized to distinguish between cell 
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surface-bound and internalized Au65 or Ag81 NPs, respectively. Qualitative and 
quantitative understanding of Ag NP-cell interactions is needed to correlate cell-
NP interactions with cytotoxicity results. 
 
 
3.4. Antimicrobial applications of nanoparticles 
According to product inventories which list NP-containing products, majority of 
the listed consumer products involve antimicrobial protection82  83. Antimicrobial 
NPs can be classified as inorganic (e.g. metal or metal oxide NPs), hybrid (e.g. 
surface modified metal oxide NPs) and organic (e.g. polymeric NPs) materials84. 
The listed applications include medical equipment coatings, cosmetic products, 
textiles, sprays etc. Depending on the (potential) NP application, the impact on 
target and non-target organisms needs to be evaluated as the toxic range for both 
types of organisms may overlap12, 85. The assessment of toxicity and/or safety can 
be complex as characteristics of NPs, the surrounding media and types of 
organisms all impact NP-cell interactions and toxic action. Among the biocidal 
NPs, Ag NPs have the most widespread use and are included in 12–24% of the 
listed products82, 83. 
Efficient silver-containing antibacterial systems can be developed by 
(i) increasing the amount of Ag used, (ii) controlling Ag NPs size, shape and 
coating to increase the rate of Ag+ release or (iii) increasing Ag concentration 
locally by increasing affinity of NPs or Ag+ towards bacteria51 while remaining 
safe for non-target organisms. Uncertainties still exist in understanding the 
mechanism of Ag NP cellular interactions and toxicity. Silver compounds still 
need to be used with caution as increase in development of bacterial silver-
resistance may occur24, 86. 
There is a growing interest in new bactericides as antibiotics resistant bacteria 
have become an increasing global health threat87. Bactericidal NMs are of great 
interest and amongst them, Ag is a promising alternative to antibiotics. The use 
of Ag NPs in combination with antibiotics has been suggested to reduce the dose 
of antibiotics, needed to achieve the same effect, by up to 1000-fold, therefore 
lowering the chances of antibiotic resistance development88. Ag NPs have shown 
to hinder the growth of bacterial biofilms, which are associated with a number of 
human infections88 and therefore could be utilized in coatings of frequently-
touched surfaces to reduce bacterial growth. 
 
 
3.4.1. Nanomaterial-based antimicrobial coatings 
Healthcare associated infections (HCAI) are a global concern and efficient 
antimicrobial coatings are estimated to decrease HCAI and the spread of anti-
biotics resistant bacteria89. Strategies for antimicrobial surfaces include (Figure 2): 
(i) antimicrobial agent-based coatings to kill microbes due to release of active 
agent90, (ii) physical surface structures or covalently anchored active substances 
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to kill microbes on contact91, 92, and (iii) surface modifications (e.g. topography 
or altered hydrophilic/hydrophobic properties) inhibiting initial microbial 
adhesion93. Thus, antimicrobial surfaces can be classified as either antibiofouling 
or bactericidal94. Metal-based microbe inhibiting surfaces (Cu, Cu alloys or Ag) 
have been used for centuries95 but as such surfaces mainly act via metal ion 
release96 they are not able to degrade the remains of dead bacteria on the surface. 
The other downsides are the change of the material appearance due to e.g. 
oxidation and cost of the material97. 
Antimicrobial NPs show great promise in respective surfaces84 as the use of 
NPs in surface coatings can increase surface efficiency due to large specific 
surface area of NPs98. Although not only metal-based NPs lead to antimicrobial 
action (e.g. chitosan NPs)99, according to meta-analysis of scientific literature99 
and relevant consumer-product databases82, 83 antimicrobial coatings most 
commonly incorporate metal (e.g. silver, titanium, copper, zinc)-based NPs. 
  
 
 
Figure 2. Scheme of different types of antimicrobial coatings. (i) antimicrobial agent 
release-based coating (ii) contact killing based coating (A – physical surface structure e.g. 
nanostructured surface, B – covalently surface-linked active agent based coating) 
(iii) anti-adhesion coatings. Modified from (Ahonen et al. 2017)99. 
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3.4.2. Photocatalytic antimicrobial nano coatings 
Photocatalyst (TiO2100, 101, ZnO102) containing antimicrobial surface is a 
promising approach to induce microbial killing and degradation of organic matter 
under specific illumination conditions in a cost-effective way. Commonly, light 
in the UV energy range is required to overcome photocatalyst band gap (energy 
required to promote electron from valence band to conduction band) and create 
electron-hole pairs which have the ability to produce well-known ROS: super-
oxide anion radicals (•O2–) and/or hydroxyl radicals (•OH). The use of nanosized 
structures in photocatalysis-dependent antimicrobial surfaces potentially enables 
to prepare highly efficient surfaces as high surface area of NM ensures the 
presence of higher amount of surface adsorbed species that can act as electron 
and/or hole traps101, therefore prolonging recombination. 
TiO2 (band gap 3.2 eV) is a well-known environmentally benign103 photo-
catalyst104, solar cell material105, anti-fogging material and self-cleaning coating 
material106, 107. Photoactivated TiO2 has the ability to destroy a wide range of 
organic contaminants including microbes. The suggested mechanism behind such 
behaviour is the degradation of membrane components by the ROS produced 
during photocatalytic processes108–109. TiO2 occurs in three different crystal 
phases (anatase, rutile, brookite) of which anatase phase is shown to produce ROS 
at higher rate compared to other TiO2 crystal phases110. Highly reactive hydroxyl 
radicals are produced during photoexcitation (generated photoholes oxidize 
surface absorbed H2O)101. Other ROS contribute to TiO2 photocatalytic activity, 
but the majority is attributed to •OH, which are shown to diffuse over short 
distances and therefore degrade organic compounds (including essential cellular 
components of microbes) that are not directly in contact with the photo-
catalyst101, 111. Thin film coatings of TiO2 are good candidates for inhibiting the 
growth of potentially pathogenic bacteria112. A proposed alternative photocatalyst 
to TiO2 is ZnO which possess similar band gap (3.37 eV) and likewise act mainly 
via photogenerated hydroxyl radicals but exhibit higher absorption efficiency 
across a large fraction of the solar spectrum113. ZnO NMs have reported to induce 
antibacterial activity through chemical (photoinduced ROS) as well as physical 
(mechanical damage) interactions114 and therefore is also a potential candidate to 
be used in antimicrobial surface coatings. 
 
 
3.4.3. Nanomaterial-based antimicrobial surfaces with combined effect 
of ion release and photocatalysis 
A way to supress the effect of the limitation that only a small fraction of photons 
in solar spectrum exceeds band gap energy of the most widespread photocatalyst 
(TiO2, ZnO)115 is to deposit noble metals (e. g. Ag) on these semiconductors 
(Figure 3A). In this case the noble metal deposition works as an electron sink and 
facilitates charge separation (inhibition of recombination) and therefore increases 
efficiency of photocatalysis (Figure 3B)116. Other possibilities include band gap 
23 
narrowing by incorporating metal atoms into crystal lattice117 or visible light 
plasmonic absorption on metal deposits with following energy transfer to semi-
conductor. The combination of TiO2 or ZnO with Ag deposits is a promising 
approach to create antimicrobial materials118. The increased antimicrobial effect 
of nano-composite semiconductor materials (e.g. ZnO+Ag) rises from improved 
photocatalytic activity and/or the release of toxic ions (Zn2+, Ag+). Ag doped ZnO 
NPs have reported to induce enhanced antimicrobial activity compared to pure 
ZnO119. Heterostructured Ag-ZnO nanorod arrays possess higher antimicrobial 
efficiency compared to bare ZnO nanorod arrays and neither arrays showed 
cytotoxicity towards mouse fibroblast cell line120, which motivate the use of Ag-
ZnO combination in development of antimicrobial surfaces with low potential 
toxicity towards human. 
 
Figure 3. Schematic illustration of Ag deposits on ZnO (A) and the proposed charge 
separation process and photocatalytic ROS generation of ZnO/Ag structures under UV-
light (B). As the energy level of ZnO conduction band (CB) is higher than Fermi energy 
level (Ef), photoinduced electrons are transferred from ZnO to Ag. Subsequently, 
electrons in the Ag sinks react with chemisorbed O2 (forming superoxide: ·O2–) and holes 
react with surface hydroxyl OH (forming hydroxyl radicals: ·OH). VB – valence band, 
Evac – vacuum level. Modified from (Lu et al. 2008)116. 
 
 
3.4.4. Preparation and efficiency testing of nanomaterial-based 
antimicrobial surfaces 
To prepare antimicrobial surfaces from NPs, the particles may be fabricated 
directly onto various supports121 or previously synthesized NPs can be deposited 
on a surface using e.g. spin-coating, drop-casting, spray-coating or electro-
phoretic deposition122. NP production can be very broadly classified into a top-
down (material is decreased from large to nanoscale) and a bottom-up (NP 
production starts from the atomic level) approach. There are various methods for 
the synthesis of NPs but in the case of TiO2 and ZnO, solution-based approach 
(e.g. hydrothermal synthesis) has been claimed to be the simplest and the least 
energy consuming113. Metal NPs are mainly synthesized using a chemical, 
physical or even biological method123. Chemical reduction is the most often 
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applied method for the preparation of stable metal NP suspensions123. In the case 
of preparing Ag NPs, a soluble metal salt (e.g. AgNO3) is often used as a source 
for Ag+ ions. The reduction of ions can be carried out using a reducing agent 
(chemical reduction)124 or irradiation (photoreduction)125 and the resulting Ag0 
atoms form NPs.  
In the case of photocatalytic materials, the photodegradation efficiency of sur-
faces is evaluated. Similarly to suspensions of photocatalytic particles which are 
mixed with solutions of model organic dye115 the NP covered surfaces are often 
suspended in a model dye solution126. After appropriate irradiation times the 
absorbance of model dye solution is measured to evaluate the photodegradation 
efficiency of the suspended particles or surfaces115, 126. 
There is no widely accepted methodology available to precisely and re-
producibly evaluate the antimicrobial efficiency of NM-based antimicrobial 
surfaces127. The antimicrobial efficiency of conventional surfaces is evaluated 
using zone of inhibition, immersive inoculation, direct inoculation or surface 
growth methods128. The three major international standards for the assessment of 
antimicrobial activity of surfaces are JIS Z2801:2010 (Antibacterial products – 
Test for antibacterial activity and efficacy), ISO 22196:2010 (Measurement of 
antibacterial activity on plastics and other non-porous surfaces) and US EPA 
(Protocol for the evaluation of bactericidal activity of hard, non-porous copper 
containing surface products)97. The standards use Staphylococcus aureus, 
Escherichia coli or Pseudomonas aeruginosa suspensions to inoculate the test 
surface. After 24 h incubation the inoculum is washed off and colony counting 
on agar plates is used to assess the bactericidal efficiency of the tested surface. 
The need to use UV-light to activate photocatalyst-containing surfaces compli-
cates the testing procedure but there is a standard (ISO 27447:2009) for testing 
antimicrobial properties of semiconducting photocatalytic materials129. The present 
thesis addressed the need for more suitable testing methods to allow higher 
throughput screening of antimicrobial properties of NM-based surfaces by 
modifying and improving the available testing standards.  
  
25 
4. MATERIALS AND METHODS 
4.1. Materials 
Reagent grade chemicals and water purified with MilliQ equipment were used 
throughout the experiments. Ag NPs used in the studies were bought: Paper I – 
Ag nanowires in powder form from Seashell Technology (USA), Paper I and II – 
citrate stabilized Ag nanosphere aqueous suspensions from MKNano (Canada); 
Paper III – citrate, bPEI and PEG stabilized Ag nanosphere aqueous suspensions 
of different sizes from nanoComposix (USA). Self-built fluorescent Hg lamp 
consisting of fluorescent light bulbs (15 W iSOLde Cleo, λmax 355 nm) was used 
in Paper IV (light intensity at sample height in 315–400 nm spectral region was 
22 W/m2) and Paper V (light intensity at sample height in 315–400 nm spectral 
region was 2.7–3.2 W/m2) for UVA-light exposures. 
 
 
4.2. Nanomaterial preparation methods 
Ag nanowires were suspended and sonicated (40 W probe sonication for 1.5–
2.5 min) before experiments. Ag nanosphere stock suspensions were diluted to 
relevant test concentrations using water (bacterial assay – Paper I and II; particle 
characterization analysis – Paper I, II, III; dissolution study – Paper I and II) or 
cell culture media (mammalian cell assays – Paper II and III; dissolution study – 
Paper III) depending on the experimental setup and requirements. The exact Ag 
concentrations in suspensions were determined by ICP-MS or AAS. 
Metal oxide NPs were prepared by hydrothermal synthesis. TiO2 particles 
were synthesized using PTSA, Ti(OBu)4 and acac as starting materials. The 
reaction was carried out overnight at reflux conditions and reaction product was 
subsequently washed with methanol and dispersed in ethanol (Paper IV). ZnO 
particles were synthesized using Zn-acetate and KOH in methanol. The reaction 
was carried out at reflux conditions for 72 h. The reaction product was washed 
with methanol and redispersed in butanol. Acac was added as a stabilizing ligand. 
ZnO/Ag composite particles were synthesized by photodeposition of Ag from 
Ag+-containing complex (silver 2-ethylhexanoate) onto ZnO particles using 
UVA-diode irradiation (120 W/m2). The product was washed with butanol 
(Paper V). 
Thin films and NP covered surfaces were prepared by spin-coating aliquots of 
colloidal solution on ethanol or acetone washed silicon or glass substrates at 
ambient atmospheric conditions. TiO2 thin films were aged at ambient conditions 
to allow evaporation of remaining solvent, subsequently annealed at 400 °C and 
washed in deionised water in ultrasonic bath to remove organic residue. ZnO and 
ZnO/Ag composite NP covered surfaces were heated at 200 °C for removal of 
organic residue. 
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4.3. Characterization of particles and surfaces 
NPs and NP covered surfaces were extensively characterized to interpret and 
report the results as accurately as possible. The primary size of NPs was measured 
using SEM (Paper I) or TEM (Paper II, III, V). Hydrodynamic size and particle 
surface charge (zeta-potential) were measured using dynamic light scattering 
(DLS) and electrophoretic light scattering, respectively (Paper I, II, III and IV). 
Elemental analysis of NPs and NP suspensions was done by SEM-EDX mapping 
(Paper I and II), STEM-EDX mapping (Paper V), TXRF or AAS (Paper I, II, III, 
V). Elemental analysis of NP covered surfaces was carried out by acid digestion 
of surface coating followed by TXRF or AAS (Paper V). UV-Vis spectroscopy 
was used to detect Ag characteristic surface plasmon resonance peak (Paper I, II 
and V) and evaluate indirect optical band gap of TiO2 (Paper IV). Surfaces 
containing NPs were characterized using Raman spectroscopy (Paper IV) or XRD 
(Paper V) to confirm crystalline structures and SEM (Paper IV, V) to visualize 
surface morphology. 
As Ag and ZnO particles are known to dissolve and Ag+ and Zn2+ ions have 
been shown to exhibit antimicrobial effect, ion release from NPs or NP covered 
surfaces was analysed. Ag NPs were incubated in conditions (exposure media 
and time) used in bioassays after which they were ultracentrifuged to separate 
particulate and ionic form. The resulting supernatant was analysed by AAS 
(Paper I and II) or ICP-MS (Paper III). Zn and Ag release from ZnO and ZnO/Ag 
composite NP covered surfaces was measured by exposing surfaces to conditions 
analogous to antimicrobial test after which Zn and Ag content in the washoff was 
analysed by TXRF or AAS. The possibility of release of NPs during antimicrobial 
testing of NP covered surfaces was checked by ultracentrifugation and 
subsequent chemical analysis of washoffs from 60 min incubated surfaces 
(Paper V). 
 
 
4.4. Antimicrobial activity, bioavailability, ROS production 
and toxicity of Ag nanoparticles (Paper I, II, III) 
Model gram-negative bacterium E. coli (Paper I, II) was used in antimicrobial 
tests. Murine fibroblast cell line Balb/3T3 (Paper II) and Jurkat human  
T-lymphocyte cell line (Paper III) were used in cell culture studies. 
Generally, in antimicrobial tests bacterial suspensions were prepared in 
appropriate concentrations and exposed to relevant concentrations of Ag NPs on 
the microplate. Depending on the organism and the assay, either inhibition of 
bioluminescence and/or inhibition of bacterial growth was used as an endpoint to 
determine half-effective concentration value (EC50). Usually, tests were repeated 
on separate days to account for inherent variability of bioassays. AgNO3 was used 
as an ionic control, samples not exposed to NPs as the negative controls. In Paper 
I and II bacterial assays were conducted in MilliQ water to avoid the potential 
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impact of Ag speciation on the test results. Bioavailability of Ag+ ions was 
evaluated by monitoring bioluminescence induction of Ag+-induced E. coli. 
Induction value of 2 was considered as induction threshold. EC50 values were 
normalized according to Ag NP dissolution and/or bioavailability. H2DCFDA 
indicator was used to evaluate the Ag NP abiotic ROS production potential. 
Increase in dye fluorescence was measured (Paper II). 
Cell culture assays for toxicity evaluation were performed on microplates in 
cell culture media. Cells were exposed to Ag NPs at 37 °C and 5% CO2. After 
24 h incubation cell viability was assessed using Neutral Red (Paper II) or 
resazurin assay (Paper III). AgNO3 was used as an ionic control, samples not 
exposed to NPs as negative controls. 
 
 
4.5. Analysis of cell-particle interactions (Paper III) 
Cell-particle interactions were studied using imaging flow cytometry and 
enhanced dark-field microscopy. For imaging flow cytometry analysis, the cells 
were washed and resuspended in PBS after exposure. For live-dead analysis the 
cells were stained with fluorescein diacetate and propidium iodide. Information 
in bright field, dark field, and fluorescence was collected in parallel. Separate 
compensation samples were used to take into account background signals. Same 
exposed suspension was used for cell counting and the remaining suspension was 
acid digested and analysed with ICP-MS for Ag content. To distinguish 
internalized Ag from cell surface-bound Ag, selective chemical etching was used. 
Exposure to the mixture of K3Fe(CN)6 and Na2S2O3·5H2O in PBS was used to 
oxidize and complex cell surface-associated Ag. Both etched and not etched 
samples were analysed by flow cytometry and ICP-MS as described above. 
Enhanced dark-field microscopy was used for high resolution visualization. After 
exposure cells were washed and resuspended in PBS and fixed with 
formaldehyde. Drop of suspension was placed on a glass slide, mounting medium 
was added, the suspension was covered with cover glass and imaged. 
 
 
4.6. Analysis of bacterial cell morphological changes and 
degradation of bacterial membrane associated  
fatty acids (Paper IV) 
For analysis of bacterial cell morphological changes, similar exposure conditions 
as for viability evaluation were used for a constantly bioluminescent E. coli strain. 
In addition, 40 and 60 min exposure times were applied. After exposure the 
samples were fixed using 2.5% glutaraldehyde and dehydrated with ethanol. The 
samples were left to dry for 3 days after which they were imaged using SEM. 
Uniform layer of fatty acid (stearic, oleic and linoleic acid) was spin-coated 
onto nano-TiO2 thin film substrate for photoactivated degradation studies. UVA 
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exposure was carried out in a climate chamber (25 °C, 70% rh) for 0, 1, 3, 5 and 
10 min. Changes in fatty acid chemical structure were evaluated by measuring 
carbon 1s XPS spectra (comprising sp2 carbon, sp3 carbon and carboxylic group) 
after each exposure using a surface station in the Institute of Physics, University 
of Tartu. 
 
 
4.7. Antimicrobial activity of nanoparticle covered surfaces 
(Paper IV, V) 
Gram-negative bacterium E. coli (IV and V), gram-positive bacterium S. aureus 
(Paper V) and fungi C. albicans (Paper V) were used as model organisms to 
evaluate the antimicrobial properties of NP covered surfaces. 
Photocatalytic metal oxide NP covered surfaces were tested for their anti-
microbial effect under UVA light. Two different protocols were used. In Paper 
IV, aliquots of bacterial suspension of a constantly bioluminescent strain of 
E. coli were dropped onto the surfaces and exposed to UVA (22 W/m2). After 
exposure (0, 5, 10, 15 and 20 min) in a climate chamber (25 °C, 90% rh) bacteria 
were washed off from the surfaces, serially diluted and aliquots of each dilution 
were spread onto LB agar plates. After overnight incubation at 37 °C colonies 
were counted. In Paper V, test protocol modified from ISO 27447:2009 was used 
for higher throughput. Aliquots of microbial suspensions were applied to the test 
surface and covered with polyethylene film. Exposure to UVA (2.7–3.2 W/m2) 
was carried out in humid environment. After exposure microbes were washed off 
from the surfaces with toxicity neutralizing agent. The washoff was serially 
diluted and each dilution was drop-plated onto nutrient agar plates. After 24–48 
h incubation at 30 °C colonies were counted. In Paper V antimicrobial activity of 
Zn2+ ions (from soluble ZnSO4) was evaluated by exposing microbial suspension 
containing relevant concentration of Zn2+ ions on an untreated glass substrate to 
UVA light. Exposure on non-coated substrates and samples kept in the dark were 
used as controls in both studies. 
 
 
4.8. Photocatalytic properties of nanoparticles and 
nanoparticle covered surfaces (Paper V) 
Photocatalytic properties of NP suspensions were evaluated. Photodegradation of 
added model dye (brilliant blue FCF) was monitored after exposure using UV-
Vis spectroscopy. 
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4.9. Reusability of nanoparticle containing surfaces  
(Paper V) 
10 cycles of use and cleaning were applied to ZnO/Ag composite NP covered 
surfaces. Antibacterial efficiency was evaluated after each cycle. Photocatalytic 
activity measurements, elemental analysis and SEM imaging were done on 
unused surfaces and surfaces after 3 and 10 use cycles. 
 
 
4.10. Statistical analysis 
MS Excel was used to calculate standard deviations and perform t-test. GraphPad 
Prism or Excel Macro Regtox (MSExcel macro REGTOX EV7.0.5.xls, available 
online at: https://www.normalesup.org/~vindimian/en_index.html) was used for 
EC50 calculations. One-way ANOVA followed by Tukey’s HSD using R was 
performed to detect statistically relevant differences in viable counts in Paper V.  
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5. RESULTS AND DISCUSSION 
5.1. The effect of Ag nanoparticle shape, size and surface 
charge on antimicrobial activity and toxicity (Paper I, II, III) 
As the effects of chemicals and materials (including NPs) are directed towards 
certain target organisms, the impact on so-called non-target organisms must be 
as low as possible. In the case of antimicrobial substances, humans are considered 
non-target organisms. Therefore, alongside antimicrobial studies towards 
bacteria cytotoxicity towards mammalian cells was evaluated. 
To study the potential shape- and size-dependent effects of Ag NPs towards 
bacterial and mammalian cells, a library of particles was tested (Table 1). Ag 
nanospheres (Ag NSs, 83 nm) were tested alongside Ag nanowires (Ag NWs, 
100 nm × 6100 nm) to study shape-dependent antibacterial activity (Paper I) 
(Figure 4). The diameters of the tested nanospheres and -wires were chosen in the 
same size range to enable relevant comparison. Different-sized citrate-coated 
spherical particles (10, 20, 40, 60 and 80 nm) (Figure 5 A) were tested towards 
model bacteria E. coli and mammalian fibroblasts to evaluate size-dependent 
antimicrobial activity and toxicity of Ag particles (Paper II). Particle sizes 
discussed hereafter are mean particle diameters, size distributions are shown in 
Table 1. In addition to primary size the hydrodynamic size of the tested particles 
in the used test media was measured to adequately interpret toxicity results. 
Bacterial assays in Paper I and II were conducted in MilliQ water to exclude Ag 
speciation driven alterations and the hydrodynamic size in MilliQ water was close 
to NP primary size. Hydrodynamic diameters in cell culture medium were bigger 
compared to MilliQ water. The increase is due to organic components found in 
the media which form a surface coating on the particles70 (Table 1). 
 
Figure 4: Scanning electron micrographs and EDX mapping (insets showing Ag Lα 
signal) of Ag nanowires and Ag nanospheres. 
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EC50 values calculated from bioluminescence inhibition (Table 2) showed 
statistically significant difference between Ag NSs and Ag NWs which indicated 
possible shape-dependent antibacterial activity towards E. coli. Size-dependent 
antibacterial activity and cytotoxicity was observed when 10 nm to 80 nm Ag 
nanospheres were tested towards bacterial and mammalian cells. The results 
showed that both increased (i.e. EC50 and IC50 values decreased) with decreasing 
particle size (Table 2). 
 
 
Figure 5. Transmission electron microscopy images of Ag nanoparticles (NPs). A – 10, 
20, 40, 60 and 80 nm Ag NPs (Paper II). B – 10, 30 and 70 nm bPEI-coated Ag NPs 
(Paper III). C – 10, 30 and 70 nm PEG-coated Ag NPs (Paper III). D – 10, 30 and 70 nm 
citrate-coated Ag NPs (Paper III). Scale bars represent 100 nm. 
 
The influence of surface charge (positive, negative and near neutral) on cytotoxicity 
was studied using human T-lymphocyte cell line (Paper III). Homogenous and 
well dispersed Ag NPs with different surface coatings (bPEI, citrate, PEG) were 
tested (Figure 5 B, C, D). Surface charge measurements confirmed different 
surface charges: bPEI-coated particles had positive surface charge (33 to 42 mV), 
citrate covered particles negative (–39 to –44 mV) and PEG covered particles 
lower negative charge (–21 to –22 mV) (Table 1). The low negative charge is 
hereafter referred to as near neutral surface coating as the surface charge value of 
PEG covered particles is the closest to 0 compared to other two surface charges. 
PEG-coated (near neutral) and citrate-coated (negative) particles were less toxic 
than bPEI-coated (positive) particles (Table 2). High toxicity of cationic Ag 
particles could be due to (i) strong binding to cell surface followed by release of 
Ag+ ions, (ii) direct damage to cell membrane, or (iii) elevated cellular uptake.
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5.2. The effect of Ag nanoparticle dissolution and 
nanoparticle-cell interactions on  
antimicrobial activity and toxicity  
To further clarify the mechanisms behind Ag NP biological effects, the tendencies 
observed earlier – increasing antibacterial activity and cytotoxicity with decreasing 
particle size and increased cytotoxicity for positively charged particles, were 
further combined with results from Ag NPs dissolution. Ag NPs are known to 
dissolve in some degree and antimicrobial activity of Ag+ ions is well 
recognized130–132. Therefore, every study that involves Ag particles should take 
into consideration particle dissolution and subsequent ion-based effects. As 
mammalian cells can internalize particles, Ag NP-cell interactions including 
particle intracellularization were also studied to understand the exact processes 
behind the observed cytotoxicity results. 
 
 
5.2.1. The effect of Ag nanoparticle dissolution on  
antimicrobial activity and toxicity (Paper I, II, III) 
Nominal EC50 values indicated shape-dependent antibacterial activity when Ag 
NWs and Ag NSs of similar diameter were tested (Table 2). However, when the 
results were normalized to the concentration of dissolved Ag (2.2–2.4% of the 
particles dissolved to ionic form) EC50 values of both Ag NPs were not 
statistically significantly different from EC50 value of the ionic control (AgNO3) 
(Table 2). That suggests that the effects were driven by dissolved Ag+ ions. Same 
conclusion was drawn when initial EC50 values were normalized to bioavailable 
Ag (Table 2) using Ag+-induced E. coli133. Antibacterial activities of Ag NWs 
suspension and its ultracentrifuged particle-free supernatant were equal further 
proving ionic toxicity mechanism (Paper I Figure 4 a). Viability assay showed 
remarkable decrease in bacterial cell count at 5–9-fold higher concentrations 
(Paper I Figure 4 b). The inhibition of bacterial bioluminescence can therefore be 
considered an adequate indicator for toxicity that reflects changes in bacterial 
energy metabolism134 and correlates significantly with cellular viability135. 
Although no shape-dependent effects were seen with ~80 nm diameter particles 
(nanospheres vs nanowires), shape-dependence may still occur with smaller sized 
particles. Indeed, shape-dependent antibacterial effect for Ag particles has been 
reported49, 50, 52 but the dissolution of the particles and influence of Ag+ ions 
wasn’t evaluated in those studies. Therefore, it can’t be ruled out that the observed 
effects could have been explained by particle dissolution as particle shape affects 
particle dissolution62. 
The influence of particle dissolution on the observed size-dependent 
antibacterial efficacy and cytotoxicity results for 10 nm to 80 nm diameter Ag 
particles (citrateMK-Ag) was assessed. Increased dissolution with decreasing 
particle136 size was observed which could be explained by increased specific 
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surface area of smaller particles. Nominal EC50 values were corrected to dis-
solution (Table 2) and it was concluded that dissolution fully explained the 
antimicrobial activity of 20 nm to 80 nm diameter particles towards bacterial cells 
and toxicity of all the particles towards mammalian cells. 
It seemed that 10 nm particles had additional non-dissolution driven anti-
bacterial properties as the efficacy was higher than could be predicted from EC50 
value of ionic control (AgNO3) (Table 2). At the same time similarities in the 
slopes of dose-response curves for AgNO3 and Ag NPs indicate that all the tested 
Ag compounds have a common mechanism of action (dissolved silver) (Paper II 
Figure 4). The hypothesis then was that 10 nm particles may induce increased 
bioavailability of Ag and/or induce ROS. The formation of abiotic ROS was 
studied by monitoring fluorescence change of ROS-sensitive dye (H2DCFDA) 
and in our case ROS was not detected at toxicologically relevant concentrations. 
In close contact with NPs, cells may release and import higher concentrations of 
metals than are dissolved in abiotic conditions21 and thus, a more relevant mea-
sure for NP-released Ag+ ions than centrifugation and bulk assessment of Ag 
should be used. For that, we measured bioavailability of Ag+ ions using Ag+-
induced E. coli133. Concentration at which bioluminescence induction of sensor 
bacteria occurred decreased with decreasing particle size which correlates with 
increased dissolution of smaller particles. Bioavailability corrected EC50 values 
indicated that intracellular bioavailable Ag explained the antibacterial efficacy 
for all the tested particles, including 10 nm particles (Table 2). Thus, we conclude 
that the major antibacterial effect of Ag NPs derives from their enhanced local 
dissolution leading to increased bioavailability of Ag. Mechanism through which 
ions become more bioavailable than abiotic dissolution suggests is claimed to be 
the increased adherence of Ag particles onto bacterial cell22. It is known that 
direct contact is essential for increased bioavailability21. Therefore, the reason for 
the increase might be greater particle-cell contact and subsequent increased 
particle dissolution in close vicinity of the bacterial cell. 
Although dissolution and release of Ag+ ions explained the effect of variously 
sized Ag NPs toward mammalian cells, Ag+ ions did not explain differences 
between differently charged particles. Cytotoxicity results showed increased 
toxic effect for positively charged particles but no obvious differences in dis-
solution of differently coated particles was observed (Paper III Table 1). It has 
been shown that cationic NPs have elevated cellular binding compared to anionic 
NPs22, 60 but the difference is rarely quantitatively assessed. Therefore NP-cell 
interactions with differently coated Ag particles were further studied with 
combined complementary analytical methods to qualitatively and quantitatively 
evaluate the difference. 
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5.2.2. Analysis of Ag nanoparticle-cell interactions affecting particle 
cytotoxicity (Paper III) 
A set of analysis methods (imaging flow cytometry, ICP-MS, dark field micro-
scopy) was used to study NP-cell interactions. Flow cytometry relies on increased 
light scattering ability of cells upon their association with NPs. Flow cytometry 
side scatter (SSC) signal has been shown to describe cell-NP interactions77, 78. 
Imaging flow cytometry enables high-throughput semi-quantitative analysis of 
the level of cellular interaction with NPs and cell viability when bright field, dark 
field and fluorescence images are collected simultaneously. No significant increase 
in flow cytometry SSC signal or obvious binding in dark field microscopy was 
seen with most PEG- (near-neutral surface charge) and citrate- (negative surface 
charge) coated Ag particles. Only cells exposed to the largest tested concentration 
(25.0 μg/mL) of 70 nm PEG- and citrate-coated particles showed slight increase 
in SSC signal. 
However, notable increase in SSC signal was revealed after 24 h exposure to 
bPEI-coated (positive surface charge) particles at a concentration as low as 
0.1 μg/mL (Figure 6, Table 3). bPEI coated particles were also seen to interact 
tightly with cells under enhanced dark field microscope which allows visuali-
zation at higher magnification (Paper III Figure 3). In both, imaging flow cyto-
metry and dark field microscopy, in the case of larger particles the binding of 
particles to cells was more obvious. Cell counting and ICP-MS analysis was used 
to obtain quantitative results for cell-bound Ag. The analysis revealed that 
although larger particles were more visible in flow cytometry and dark field 
microscopy, the amount of Ag bound to each cell was similar for all bPEI-coated 
particles. ICP-MS analysis further clarified that compared to bPEI-coated 
particles, the cellular binding of citrate-coated and PEG-coated particles was 4-
fold and 25-fold lower, respectively (Table 3). 
Cellular localization of Ag particles was analysed using selective chemical 
etching81 which allowed to separate cell surface associated and intracellular Ag. 
The removal of cell surface associated particles was observable from changes in 
the flow cytometry SSC signal (Figure 7). It was seen that at IC50 concentration 
the total amount of Ag NPs bound to cells was higher for bPEI-coated particles, 
but intracellular concentration of Ag was remarkably similar (Table 3). There-
fore, we suggest that the cytotoxicity of different Ag NPs is mostly influenced by 
their internalization capability and is not directly influenced by cell surface 
associated Ag NPs. Dissolution of internalized Ag particles has been indicated30, 137 
and therefore we indirectly evaluated the dissolution of internalized Ag NPs by 
comparing intracellular concentrations of Ag at IC50 values of Ag NPs and 
AgNO3. The analysis revealed 4.5–9-fold higher intracellular Ag concentrations 
in the case of Ag NP-exposed cells suggesting that significant fraction of Ag NPs 
was present in nanoparticulate form. 
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Figure 6. Association of 10 nm bPEI- (positive surface charge), PEG- (near neutral 
surface charge) and citrate- (negative surface charge) coated Ag nanoparticles (NPs) with 
human T-lymphocyte cells according to imaging flow cytometry histograms. SSC — side 
scatter indicating cell-associated Ag NPs.  
 
 
 
Figure 7. The effect of removal of cell surface associated 10 nm bPEI-coated Ag nano-
particles (NPs) with chemical etching according to flow cytometry histograms. SSC – 
side scatter indicating cell-associated Ag NPs. 
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It has been claimed in previous studies77, 78 that flow cytometry analysis 
provides mainly information about intracellular NPs. Our study revealed that 
after chemical etching of surface-bound particles SSC signal disappeared. Thus, 
we suggest that SSC signal mainly originates from surface-associated particles. 
ICP-MS analysis showed that although etching removed significant fraction of 
Ag (as average 85%, 67% and 62–79% of bPEI-, citrate- and PEG-coated 
particles, respectively), there was still clear difference between intracellular 
concentrations of Ag NPs with different coatings at the same exposure 
concentrations (Paper III Figure 5). Decreased cellular uptake with increased 
particle size was also seen and the result is consistent with previous studies58, 60. 
As Ag NPs are suggested to be internalized through clathrin or caveolin-mediated 
endocytosis29 high-affinity binding of cationic particles to cellular membrane 
explains the increased endocytosis activity.  
On the basis of our study we recommend not to use positively charged Ag 
particles in antimicrobial applications as more intracellularization occurs and 
particles tend to be more toxic to mammalian cells than negatively and near-
neutrally charged particles. Our results indicate that mammalian cells are less 
susceptible to Ag toxicity than bacteria (IC50 values ~10 times higher; Table 1) 
whilst it has been shown that the toxic range of Ag NPs to bacteria and 
mammalian cells may overlap12, 15. Thus, the toxicity of particles towards non-
target organisms still needs to be considered when following a safe-by-design 
principle in product development.  
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5.3. The application of antimicrobial and photocatalytic 
nanoparticles in antimicrobial surface coatings 
To address the need for more efficient antimicrobial surfaces, NP-based surface 
coatings were prepared and ways to improve surface efficiencies were studied. 
Photocatalytic surfaces induce microbial killing and are able to degrade excess 
organic matter, therefore photocatalytically active metal oxides were chosen as 
the primary particle material. Firstly, TiO2 was chosen to prepare NP-based thin 
films because TiO2 is the most known and used photocatalyst100. The use of non-
dissolvable particles enabled to initially study photocatalysis-driven antibacterial 
effects without additional complex ion-induced activity. Secondly, the importance 
of particle dissolution and the high antibacterial effect of Ag+ ions discussed in 
the previous chapters was the motivation behind supplementing a dissolvable 
photocatalytic metal oxide particle (ZnO) with Ag NPs in the following study to 
combine photocatalytic and ionic effects. 
Based on current literature, solution-based synthesis methods are the least 
energy consuming113 and therefore, hydrothermal synthesis was used to prepare 
NP suspensions in both studies. Spin-coating was chosen as a quick and simple 
method to cover surfaces with the prepared NP suspensions. The prepared surfaces 
were exposed to UVA-light to initiate photocatalysis-driven effects. 
 
 
5.3.1. Mechanism of photoinduced toxicity of  
TiO2 nanoparticle based thin films (Paper IV) 
Suspension of synthesized anatase TiO2 NPs with hydrodynamic size less than 
10 nm was spin-coated onto silicon substrates to prepare ~115 nm thick nano-
particulate thin films (Figure 8 A). High specific surface area (150 m2/g, calculated 
using particle diameter) ensured the presence of significant amount of surface 
adsorbed species that can act as electron and/or hole traps110 thus increasing the 
efficiency of the photocatalyst by increasing the lifetime of electron-hole pairs.  
Time-dependent antibacterial effect of the prepared thin films under UVA-
light activation was studied using recombinant bioluminescent E. coli as a model 
microorganism (potential pathogen and sanitary indicator bacterium) for lumine-
scence-based assessment of cell viability. The possibility to use long wavelength 
UV-light (UVA) to activate TiO2 photocatalysis is a good alternative to direct 
irradiation of microbes with short wavelength UV-light (UVC) which is 
germicidal itself but is more harmful to living organisms per se. The applied UVA 
intensity (22 W/m2) corresponds to UVA intensity in solar spectrum138. The 
ability of exposed bacteria to form bioluminescent colonies on agarized growth 
media was determined together with visual inspection of bacterial morphology to 
evaluate antibacterial effects of UV-treated nano-TiO2 thin films. After 5 min 
exposure to UVA on nano-TiO2 thin films, the colony forming ability of E. coli 
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Figure 8. Nano-TiO2 thin film and colony forming potential of bioluminescent Escherichia 
coli in different exposure conditions. A) SEM image of nano-TiO2 thin film. B) the effect 
of UV-irradiation duration on colony forming potential of E. coli applied onto Si-
monocrystal substrates or nano-TiO2 thin films. After 20 min of exposure on nano-TiO2 
thin film to UVA light, no viable cells able to grow on agar plate, were observed (marked 
with n.o. – not observed). The colony forming potential of E. coli on surfaces kept in the 
dark was determined only in the beginning (0 min) and at the end of the experiment 
(20 min). 
 
As expected, only a slight decrease was seen when E. coli was exposed to UVA 
light on pure silicon control substrates. Bacterial inactivation on TiO2 thin film 
after just 20 min UVA exposure was remarkably more effective than in previous 
studies with similar UVA exposure conditions139, 140. 
Photocatalysis driven morphological changes in bacterial cells were visualised 
by SEM imaging. SEM imaging revealed that as viable luminescent bacterial 
number decreased, the shape of bacteria became more expanded and the structure 
of the bacterial cell membrane was distorted (Figure 9). A halo surrounding the 
bacteria was observed which might be caused by leakage of organic material from 
the cell as a result of cell membrane damage. Even though all the bacteria were 
killed after 20 min UVA exposure, cellular debris was still visible under SEM 
after 60 min illumination (Paper IV Figure S9). Therefore, it can be suggested 
that considerably longer time is needed to completely decompose and degrade 
bacterial cells than the time needed to affect bacterial viability. 
decreased 4 times and after 20 min exposure no colony forming bacterial cells 
were detected (Figure 8 B). 
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Figure 9. Images of survival of bacteria under UVA-light on control surfaces (upper 
block of panels) and on nano-TiO2 thin films (lower block of panels). Different sectors of 
agar plates show the colonies of luminescent bacteria in 102, 103 and 104-fold dilutions of 
UV-exposed bacterial suspension. The photos were taken in the dark. Inset on each image 
is an SEM image of the bacteria after the respective exposure conditions. Scale bars on 
SEM images correspond to 2 µm. 
 
To elaborate the mechanism of action of nano-TiO2 thin films UVA-illumination 
induced changes in chemical structure of the most abundant fatty acids in 
bacterial plasma membrane (stearic, oleic and linoleic acid)141–143 were examined 
by x-ray photoelectron spectroscopy (XPS). It was seen that saturated fatty acid 
(stearic acid) directly degraded during UVA exposure, but unsaturated fatty acids 
(oleic and linoleic acid) went through changes in their chemical composition 
before total degradation (Paper IV Figure 3). Although photo-oxidation of the 
three fatty acids passed several stages, the time required for total photo-degra-
dation (10 min) was similar for them all. It has been shown that cell membrane 
susceptibility to TiO2 photo-oxidation can be linked to the degree of unsaturation 
of fatty acid chains of phospholipids108, 144. Our study suggested that the loss of 
integrity of the main cellular outer barriers and bacterial envelope is the cause for 
antibacterial effect of photo-activated nano-TiO2 thin film. Our statement is in 
agreement with a report by Kubacka et al.101 showing the importance of cell wall 
and cell membrane related biological processes in the antibacterial activity of 
TiO2 NP containing thin films. 
 
 
5.3.2. Antimicrobial effect of ZnO and ZnO/Ag composite  
nanoparticle covered surfaces (Paper V) 
A well-known and widely used photocatalyst besides TiO2 is ZnO. Nanosized 
ZnO is partially soluble and the released Zn2+-ions are known to have anti-
microbial properties102. Thus, ZnO was chosen as an ion-releasing photocatalytic 
metal oxide material to prepare NP covered photocatalytic and antimicrobial 
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surfaces. Ag was photodeposited onto ZnO particles to increase photocatalytic 
efficacy by acting as an electron sink and therefore prolonging electron-hole pair 
lifetime145–147. Zn2+ and Ag+ ions are both known for their antimicrobial effect 
and therefore the prepared NP covered surfaces were expected to have a combined 
effect of increased photocatalysis and released metal ions. 
Well-defined and clearly separated ~80x30 nm rod-like ZnO particles were 
synthesized using hydrothermal method. ZnO particles were stabilized in butanol 
using acac and Ag was photodeposited onto ZnO particles using UVA illumi-
nation. Ag concentrations were chosen on the basis of previous research on 
ZnO/Ag composite particles115, 116, 145, 146, 148–150. The morphology of ZnO and 
ZnO/Ag composite particles was similar according to TEM. STEM-EDX analysis 
revealed silver depositions on ZnO particles (Figure 10 A). UV-Vis measure-
ments of suspensions demonstrated localized surface plasmon resonance peak at 
~425 nm which is characteristic to Ag NPs151 (Figure 10 B). XRD analysis 
showed the presence of crystalline ZnO148. Ag structure was not detected with 
XRD which might be because of the very low amount of Ag or amorphous phase 
of Ag (Paper V Figure S3). Aliquots of ZnO or ZnO/Ag composite NP sus-
pensions were applied to glass substrates by spin-coating to prepare particle 
covered surfaces. It is noteworthy that NP covered surfaces (immobilized NPs) 
have been significantly less studied for their antimicrobial activity than NPs in 
the form of a suspension. 
Figure 10. Characterization of ZnO and ZnO/Ag NPs in STEM, EDX and UV-Vis. A: 
HAADF- STEM images and EDX mapping of ZnO/Ag composite NPs. HAADF-STEM 
images combined with EDX mapping results show silver (Ag) Lα in blue, zinc (Zn) Kα in 
violet and oxygen (O) Kα in green. Scale bars correspond to 30 nm. B: UV-Vis absorbance 
spectra of ZnO and ZnO/Ag composite NP suspensions. Surface plasmon resonance peak 
at ~425 nm is characteristic to Ag NPs. 
 
Two different surface coverage densities were used to evaluate the influence of 
the amount of ZnO on the surface. Three concentrations of Ag were chosen to 
evaluate the influence of Ag on photocatalytic and antimicrobial effect. The 
surfaces contained either 2 µg Zn (in the form of ZnO) and 0, 0.005, 0.014 or 
0.022 µg Ag (sparse coverage) or 20 µg Zn (in the form of ZnO) (dense coverage) 
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per cm2. SEM indicated even coverage of ZnO particles on all prepared surfaces 
and no visual difference between pure ZnO and Ag supplemented ZnO covered 
surfaces was seen (Figure 11). Photodegradation of model dye by all NP sus-
pensions was characterized to check the influence of added Ag deposits on 
photocatalytic activity. The most remarkable increase compared to pure ZnO was 
seen with composite particles with the highest silver content (Figure 12 A). It has 
been claimed that the observed increase is the result of added Ag acting as an 
electron sink and prolonging the lifetime of electron-hole pairs. Photodegradation 
of dye also depended on ZnO concentration as was expected (Figure 12 B). 
 
 
Figure 11. SEM images of ZnO and ZnO/Ag composite NP covered surfaces. Scale bars 
correspond to 10 µm (upper panels) or 1 µm (lower panels). 
 
 
Figure 12. Photocatalytic activity of ZnO and ZnO/Ag NPs under UVA irradiation. 
A: 0.6 wt% ZnO and ZnO/Ag composite NP suspensions and B: 10× more diluted 
suspensions compared to A of 0.6 and 5 wt% ZnO NPs; all suspensions were in butanol 
with model dye. Control – model dye (brilliant blue FCF) solution. Graphs represent 
averages and standard deviations (due to small values not visible on the graphs) of three 
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experiments. X-axis – UVA irradiation time (min). Y-axis – change in absorbance of 
model dye at characteristic wavelength (630 nm) (C/C0). 
For antimicrobial activity testing of the prepared surfaces, improved test protocol 
was developed based on ISO 27447:2009 for higher throughput. Our modified 
test protocol enabled quantification of the decrease in viable microbial counts by 
three logs and therefore fulfils the requirement for 99.9% decrease of microbes 
on surfaces as required by the US standards but does not allow the assessment of 
4–5 log decrease as required by the EN standards for surfaces in healthcare 
settings. Three model pathogenic organisms were used: E. coli, S. aureus and C. 
albicans. Antimicrobial efficiency of our ZnO and ZnO/Ag surfaces in the dark 
was relatively small (Figure 13 A, C and E). Though, after 60 min incubation the 
toxic effect of ZnO covered surfaces became statistically relevant (Paper V 
Figure 5). Also, sparse coverage ZnO surface with the highest Ag content showed 
significant effect in the dark causing >3 log reduction of E. coli and S. aureus 
after 60 min incubation (Figure 13 A and C). In the applied test conditions, 
S. aureus seemed to be more sensitive to surfaces-induced effects than E. coli. 
C. albicans was the least sensitive. 
Surfaces were notably more effective under UVA illumination (Figure 13 B, 
D, F). UV-induced antimicrobial activity of surfaces was dependent on ZnO 
content. Dense coverage ZnO surfaces enabled ~2 log reduction of viable bacterial 
cells already after 15 min incubation and can be considered very efficient. Further 
incubation resulted in reduction of viable counts exceeding our limit of 
quantification. For practical application, short killing times are preferred and 
therefore 24 h incubation time required in the current standards has been 
criticized97. The addition of Ag to ZnO generally increased antimicrobial activity. 
The effect of the surfaces with the highest Ag content was the most significant 
and after less than 30 min illumination resulted in >3 log reduction of viable 
bacteria. The effect was the lowest for C. albicans, likely due to higher resistance 
of fungal cells152 and only 0.6 log reduction occurred after 60 min incubation. 
Our tests showed that NPs were not released from the surfaces during the 
exposures, therefore in addition to photocatalytic activity, only released ionic Zn 
and Ag can add to antimicrobial efficiency. We exposed bacterial cells to Zn2+ 
ion (from soluble ZnSO4) concentrations which corresponded to the amounts of 
ions released from the surface (determined by dissolution experiments) (Paper V 
Figure S5) to study the influence of Zn2+ ions on overall toxicity. No toxicity was 
seen toward S. aureus and C. albicans. However, significant dose-independent 
effect was observed for E. coli. S. aureus has been shown to be less susceptible 
to Ag-ZnO treatment than E. coli, probably due to weaker antioxidant cellular 
content of E. coli that renders the latter less resistant to oxidative stress153, 154. 
Comparison of toxicity of surfaces with ionic toxicity also showed difference 
between E. coli and the other two test organisms. Thus, for E. coli it would be 
plausible to explain surface toxicity with the release of metal ions or oxidative 
stress. However, ZnO surfaces were lacking dose effect in the dark but had a clear 
dose-dependent difference under UVA which confirms photocatalysis as the 
main contributor to the antimicrobial effect. 
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Figure 13. Viability of microorganisms on ZnO and ZnO/Ag surfaces in the dark and 
under UVA illumination. Viability of Escherichia coli (A and B), Staphylococcus aureus 
(C and D), Candida albicans (E and F) exposed to ZnO and ZnO/Ag composite NP 
covered surfaces, expressed in colony forming units (CFU). Left – surfaces kept in the 
dark as control. Right – UVA exposed surfaces. Graphs represent averages and standard 
deviations of three experiments. Dotted line: limit of quantification for CFUs. 
 
Increased photocatalytic activity in the case of higher amount of ZnO or increased 
Ag content in ZnO/Ag composites was as well confirmed by model dye photo-
degradation test (Figure 12). Other previously published papers have reported 
that ROS155–157 and slow release of metal ions158 are the main mechanisms driving 
the toxicity of ZnO/Ag containing materials. We observed relatively low release of 
Zn2+ ions from our surfaces even under UVA illumination. As these concentrations 
were not toxic for S. aureus and C. albicans, we suggest the possibility for 
additional local release of Zn near cell walls159. Our study didn’t involve testing 
of ROS production and therefore further research is needed to clearly distinguish 
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between effects caused by the ions and ROS. Photodegradation of membrane 
associated fatty acids is probably also occurring as was shown in Paper IV. 
For practical applications, the reusability of antimicrobial surfaces is extremely 
important. We tested the antibacterial efficacy of sparse coverage ZnO surfaces 
with the highest Ag content during 10 usage cycles. Although TXRF and AAS 
analysis showed decreased Zn and Ag content of the surfaces after usage cycles, 
we didn’t observe significant decrease in neither antibacterial activity (Paper V 
Figure 7) nor photodegradation capability of the surface (Paper V Figure S7). 
According to our knowledge, our study is the first to demonstrate the reusability 
of ZnO/Ag surfaces for antimicrobial applications. The use of Ag NPs showed 
increased photocatalytic and antimicrobial activity even in very low concent-
rations (0.005, 0.014 or 0.022 µg Ag per cm2) and therefore, ZnO/Ag combi-
nation can be considered a perspective material in antimicrobial coatings.  
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CONCLUSIONS 
Novel properties of nanosized materials are exploited in numerous consumer 
products and in product development. The increased interest in the use of 
nanomaterials (NMs) has created a need for better understanding of their influence 
on relevant organisms. The most widely used NMs in consumer products are 
silver nanoparticles (Ag NPs) and the respective applications mainly exploit the 
antimicrobial nature of Ag. In addition to favorable properties, the newly 
developed NMs may induce unwanted effects towards non-target organisms. The 
main aim of the current study was to design novel antimicrobial Ag NP-containing 
surfaces. Therefore, the current thesis includes studies about the toxicity and the 
mechanism of toxicity of a library of Ag NPs towards microbial and mammalian 
cells and the use of NPs in antimicrobial coatings. The focus has been on under-
standing the influence of particle physico-chemical properties on their 
antimicrobial activity and toxicity towards mammalian cells to be able to 
recommend the use of the most adequate materials in antimicrobial product 
development. The possible application of NPs in antimicrobial coatings was 
studied as that field of NP use has been under constant increased interest. 
The thesis showed that in the case of rather large Ag NPs (~80 nm in diameter) 
the effect towards model bacterium Escherichia coli was not shape-dependent 
(nanospheres vs nanowires) and could be fully explained by particle dissolution 
and bioavailability of Ag+ ions. A library of variously sized spherical Ag particles 
(10, 20, 30, 40, 60, 70 and 80 nm) was studied and increased antimicrobial activity 
and toxicity with decreasing particle size was observed. It was seen that Ag 
particles were ~10 times less toxic to mammalian cells than to bacterial cells and 
the effect towards mammalian cells was explained by the release of Ag+ ions. For 
20 nm to 80 nm Ag NPs, the size-dependent antimicrobial activity was explained 
by increased particle dissolution but the effect of 10 nm particles couldn’t be 
explained by abiotic dissolved Ag. The nano-specific effect of 10 nm particles 
was further studied and it was confirmed that increased bioavailability of Ag+ 
ions was the reason for increased antimicrobial efficacy. Although the 
mechanism of increased bioavailability of Ag+ ions from 10 nm Ag particles is 
not clear, it is hypothesized to arise from processes happening in close vicinity of 
the cell. As overall particle dissolution in abiotic conditions does not always 
explain the complex mechanism of Ag biological effects, additional research is 
needed to clarify the mechanism of influence. 
In addition to particle shape and size it is important to understand the influence 
of particle surface charge on toxicity as different particle coatings are used in 
various applications. The effect of a library of Ag particles with different surface 
coatings (branched polyethylenimine, citrate, polyethylene glycol) and 
subsequently different surface charges (positive, negative, near-neutral) towards 
mammalian cells was studied. NP-cell interactions were studied to explain the 
mechanism through which Ag particles influence the cells. Positively charged 
particles were seen to cause higher cytotoxicity and bind to cells more effectively 
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than particles with negative and neutral surface charge. Cell-bound and 
intracellular Ag was quantitatively distinguished from each other and comparable 
intracellular Ag concentrations were observed at half maximal inhibitory 
concentrations of all the particles. This suggests that internalization capability of 
particles significantly influences their cytotoxicity. 
As the spread of multidrug resistant microbes has raised the need for new 
antimicrobial treatments, the current thesis addressed the issue of NP-based 
antimicrobial surfaces. Photocatalytic material-based NP covered surfaces were 
prepared as photocatalysis is known to result in degradation of organic matter 
including microbes. First, non-soluble photocatalytic NPs (TiO2) were prepared 
and coated onto substrates by spin-coating to understand the mechanisms through 
which immobilized photocatalytic NPs cause antibacterial activity. SEM imaging 
confirmed that damages to bacterial cell envelope occur in the same time frame 
as bacterial inactivation in the viability study. Decomposition of common fatty 
acids of bacterial plasma membrane was suggested to be the reason for morpho-
logical changes and leakage of bacterial cell components that was observed in 
SEM. Next, the use of Ag NPs in combination with ion-releasing photocatalytic 
NPs (ZnO) was studied to understand the influence of Ag on photocatalytic 
activity and to develop highly efficient coatings based on a combined effect of 
photocatalysis and antimicrobial ions. High efficiency was expected as both 
materials were ion-releasing and both ions (Zn2+, Ag+) are known to have 
antimicrobial activity. The developed ZnO/Ag NP-based coatings showed high 
antimicrobial activity however a straightforward ionic effect towards the studied 
microbes (bacteria, fungi) was not proven. The observed effect was potentially 
mostly photocatalysis-driven. 
Reusability of the prepared surfaces was tested and no significant decrease in 
neither antibacterial activity nor photodegradation capability was observed after 
10 usage cycles. According to our knowledge, our study was the first to demon-
strate the reusability of ZnO/Ag surfaces for antimicrobial applications. Alto-
gether it was shown that the addition of Ag increased photocatalytic effect and 
antimicrobial efficiency of the prepared surfaces and therefore Ag can be con-
sidered a suitable material to increase the efficiency of photocatalytic material-
based antimicrobial coatings. 
Results of the present thesis support the use of Ag NPs in combination with 
photocatalytic NPs to prepare efficient antimicrobial coatings that in addition to 
microbial killing also potentially degrade surface contaminating organic matter 
(including microbes). In addition, the results suggest avoiding the use of positively 
charged Ag NPs in human directed products as cationic particles presented notably 
higher toxic effect to mammalian cells. 
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SUMMARY IN ESTONIAN 
Metalliliste nanoosakeste disain ja  
füüsikalis-keemiline iseloomustamine ning  
nende rakendamine antimikroobsetes pinnakatetes 
Uudsete omadustega nanosuuruses materjale rakendatakse arvukates tarbe-
kaupades ning tootearenduses. Suurenenud huvi nanomaterjalide kasutuse vastu 
on tekitanud vajaduse paremini aru saada nende mõjust ümbritsevale, sest lisaks 
soovitud omadustele võivad need esile kutsuda soovimatuid mõjusid mitte-
sihtorganismidele. Tarbekaupades enimkasutatud nanomaterjal on hõbe (edaspidi 
Ag) ning peamiselt rakendatakse toodetes Ag antimikroobset toimet. 
Käesoleva dissertatsiooni peamiseks eesmärgiks oli disainida Ag nanoosakesi 
sisaldavad uudsed antimikroobsed, ent mitte-sihtorganismidele (sh inimestele) 
ohutud pinnakatted. Soovitamaks antimikroobsete toodete arenduseks kõige 
sobivamaid materjale, uuriti Ag, TiO2 ja ZnO nanoosakeste antimikroobset 
toimet ning mürgisust imetajarakkudele, nanoosakeste füüsikalis-keemiliste 
omaduste mõju antimikroobsusele ja mürgisusele ning toimemehhanisme. 
Antud tööst selgub, et suurte Ag nanoosakeste puhul (~80 nm läbimõõduga) 
ei sõltu nende toime mudelbakterile Escherichia coli osakese kujust (nanosfäärid 
vs nanotraadid), vaid on täielikult seletatav osakese lahustuvuse ja Ag+ ioonide 
biosaadavusega. Erineva suurusega (10, 20, 30, 40, 60, 70 ja 80 nm) sfääriliste 
Ag osakeste puhul leiti, et osakese suuruse vähenedes suurenes nende anti-
mikroobne toime ja mürgisus. Leiti, et Ag osakesed olid imetajarakkudele ~10 
korda vähem mürgised kui bakteritele ning mõju imetajarakkudele oli seletatav 
vabanenud Ag+ ioonidega. 20–80 nm läbimõõduga osakeste puhul oli osakese 
suurusest sõltuv antibakteriaalne toime samuti seletatav suurenenud lahustu-
vusega. Sama järeldus ei kehtinud 10 nm osakeste puhul ning edasised uuringud 
näitasid, et 10 nm osakeste suurenenud antibakteriaalsus tulenes Ag+ ioonide 
suurenenud biosaadavusest, mis eeldatavalt tuleneb bakteriraku piirpinnal toimu-
vatest protsessidest. Ag osakeste keerukat mõjumehhanismi uurides peab seega 
arvestama, et abiootilistes tingimustes mõõdetud osakese lahustuvus ei pruugi 
täielikult seletada osakese mürgisust bakteritele ning mõjumehhanismi selgita-
miseks on vajalikud täiendavad uuringud. 
Kuna rakendustes kasutatakse erineva kattega osakesi, on lisaks osakese kujule 
ja suurusele oluline mõista ka pinnalaengu mõju mürgisusele. Kirjeldatud mõju 
selgitamiseks uuriti erinevalt kaetud (hargnenud polüetüleenimiin, tsitraat, polü-
etüleenglükool) ning sellest tulenevalt erineva pinnalaenguga (positiivne, nega-
tiivne, neutraalse-lähedane) Ag nanoosakeste mõju imetajarakkudele. Kaasne-
vate mõjumehhanismide selgitamiseks uuriti nanoosakeste ja rakkude vahelisi 
vastasmõjusid. Võrreldes negatiivselt ja neutraalse-lähedaselt laetud osakestega 
täheldati positiivse pinnalaenguga osakeste puhul suurenenud mürgisust ja 
efektiivsemat imetajarakuga seondumist. Rakumembraaniga seondunud ja 
rakusisest Ag-d eristati kvantitatiivselt ning näidati, et kõikide osakeste puhul oli 
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keskmiselt pärssiva kontsentratsiooni juures rakusisese Ag kogus sarnane. Nähtu 
põhjal võib eeldata, et osakeste rakku sisenemise võime mõjutab märkimis-
väärselt nende mürgisust ning positiivse pinnalaenguga osakesed mõjuvad 
imetajarakkudele oluliselt mürgisemalt. 
Multiresistentsete mikroobide levik on tekitanud vajaduse uudsete anti-
mikroobsete toodete järele ning seepärast tegeles käesolev dissertatsioon nano-
osakestel põhinevate antimikroobsete pindadega. Fotokatalüüsi käigus lagun-
datakse orgaanilist ainet, sealhulgas mikroobe, ning seepärast kasutati pindade 
katmiseks fotokatalüütilisi nanoosakesi. Esmalt valmistati immobiliseeritud 
fotokatalüütiliste nanoosakeste antibakteriaalsuse mehhanismide uurimiseks 
vurrkatmise teel mittelahustuvate fotokatalüütiliste osakestega (TiO2) kaetud 
pinnad. Skaneeriva elektronmikroskoopia (SEM) uuringud kinnitasid, et kahjus-
tused bakterite kestale ilmnesid samaaegselt elumuse uuringus nähtud bakterite 
inaktiveerumisega. SEMi uuringus nähtud bakterikesta morfoloogiliste muutuste 
ja bakteriraku sisu lekkimise põhjuseks oli oletatavalt bakteri plasmamembraanis 
sisalduvate rasvhapete lagunemine. Järgnevalt uuriti Ag nanoosakeste koosmõju 
lahustuvate fotokatalüütiliste nanoosakestega (ZnO), et mõista Ag mõju foto-
katalüüsi aktiivsusele ja arendada fotokatalüüsi ja antimikroobsete ioonide koos-
mõjus suure efektiivsusega pinnakatteid. Suure antimikroobse efektiivsuse eeldus 
oli mõlema materjali osaline lahustuvus ning Zn2+ ja Ag+ ioonide antimikroobsed 
omadused. ZnO/Ag nanoosakestel põhinevad pinnakatted olid kõrge antimik-
roobse efektiivsusega, kuid otsest ioonidest tulenevat efekti uuritud mikroobidele 
(bakterid, pärmseen) ei tõestatud. Nähtud mõju näis põhiliselt tulenevat foto-
katalüüsist. 
Väljatöötatud pinnakatete korduvkasutatavuse hindamine näitas, et pinna-
katete antibakteriaalne aktiivsus ja fotokatalüütilise lagundamise võime ei vähe-
nenud märkimisväärselt ka pärast kümmet kasutustsüklit. Meile teadaolevalt oli 
meie uurimus esimene, mis näitas ZnO/Ag pindade korduvkasutatavust anti-
mikroobses rakenduses. Kokkuvõtvalt näidati, et Ag lisamine suurendas pindade 
fotokatalüütilist ja antimikroobset mõju ning seepärast on Ag sobiv fotokatalüüti-
listel materjalidel põhinevate antimikroobsete pinnakatete efektiivsuse suurenda-
miseks. 
Käesoleva dissertatsiooni tulemused toetavad Ag nanoosakeste kombineeri-
mist fotokatalüütiliste materjalidega efektiivsete antimikroobsete ning orgaanilist 
ainet (sh mikroobe) lagundavate pinnakatete valmistamisel. Ühtlasi võib saadud 
tulemuste põhjal soovitada positiivse pinnalaenguga Ag nanoosakeste kasutamise 
vältimist toodetes, millega inimene vahetult kokku puutub, sest sellised osakesed 
olid imetajarakkudele märkimisväärselt mürgisemad kui negatiivse või neut-
raalse laenguga osakesed. 
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